ReviewJournal of personalized medicine2022

Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis.

Fabio Cacciapaglia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.